Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoff Hackett

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Sexual Medicine|May 25, 2016
Coronary Heart Disease, Diabetes, and Sexuality in MenGeoff Hackett, Michael Krychman, David Baldwin, et al.
The Journal of Sexual Medicine|April 6, 2016
Cancer, Benign Gynecology, and Sexual Function--Issues and AnswersNelson Bennett, Luca Incrocci, David Baldwin, et al.
The Journal of Sexual Medicine|July 31, 2018
The 2018 Revision to the Process of Care Model for Evaluation of Erectile DysfunctionJohn P Mulhall, Annamaria Giraldi, Geoff Hackett, et al.
Clinical Endocrinology|March 16, 2026
A Single Centre Study to Describe the Changes in Serum Testosterone Concentration Following Application of Testosterone Gel in Post-Menopausal Women With Hypoactive Sexual Desire Disorder (HSSD) Already Receiving This as Part of Usual Care in Conjunction With Oestrogen-Containing Hormone Replacement Treatment (HRT)Adrian Heald, Yasitha Illangasekera, Hassan Rehman, et al.
The Journal of Sexual Medicine|July 31, 2018
The 2018 Revision to the Process of Care Model for Management of Erectile DysfunctionJohn P Mulhall, Annamaria Giraldi, Geoff Hackett, et al.
Research in Social & Administrative Pharmacy : RSAP|July 31, 2018
The pharmacist's role in improving the treatment of erectile dysfunction and its underlying causesDavid G Taylor, Francois Giuliano, Geoff Hackett, et al.
Mayo Clinic Proceedings|October 22, 2024
Androgen Society Position Paper on Cardiovascular Risk With Testosterone TherapyAbraham Morgentaler, Sandeep Dhindsa, Adrian S Dobs, et al.
Heart (British Cardiac Society)|July 29, 2016
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortalitySimon G Anderson, David C Hutchings, Mark Woodward, et al.
The Journal of Sexual Medicine|April 5, 2014
Testosterone supplementation and sexual function: a meta-analysis studyGiovanni Corona, Andrea M Isidori, Jaques Buvat, et al.
Human Fertility (Cambridge, England)|December 2, 2010
Androgens, health and sexuality in women and menKevan Wylie, Margaret Rees, Geoff Hackett, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Sexual Medicine|May 25, 2016
Coronary Heart Disease, Diabetes, and Sexuality in MenGeoff Hackett, Michael Krychman, David Baldwin, et al.
The Journal of Sexual Medicine|April 6, 2016
Cancer, Benign Gynecology, and Sexual Function--Issues and AnswersNelson Bennett, Luca Incrocci, David Baldwin, et al.
The Journal of Sexual Medicine|July 31, 2018
The 2018 Revision to the Process of Care Model for Evaluation of Erectile DysfunctionJohn P Mulhall, Annamaria Giraldi, Geoff Hackett, et al.
Clinical Endocrinology|March 16, 2026
A Single Centre Study to Describe the Changes in Serum Testosterone Concentration Following Application of Testosterone Gel in Post-Menopausal Women With Hypoactive Sexual Desire Disorder (HSSD) Already Receiving This as Part of Usual Care in Conjunction With Oestrogen-Containing Hormone Replacement Treatment (HRT)Adrian Heald, Yasitha Illangasekera, Hassan Rehman, et al.
The Journal of Sexual Medicine|July 31, 2018
The 2018 Revision to the Process of Care Model for Management of Erectile DysfunctionJohn P Mulhall, Annamaria Giraldi, Geoff Hackett, et al.
Research in Social & Administrative Pharmacy : RSAP|July 31, 2018
The pharmacist's role in improving the treatment of erectile dysfunction and its underlying causesDavid G Taylor, Francois Giuliano, Geoff Hackett, et al.
Mayo Clinic Proceedings|October 22, 2024
Androgen Society Position Paper on Cardiovascular Risk With Testosterone TherapyAbraham Morgentaler, Sandeep Dhindsa, Adrian S Dobs, et al.
Heart (British Cardiac Society)|July 29, 2016
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortalitySimon G Anderson, David C Hutchings, Mark Woodward, et al.
The Journal of Sexual Medicine|April 5, 2014
Testosterone supplementation and sexual function: a meta-analysis studyGiovanni Corona, Andrea M Isidori, Jaques Buvat, et al.
Human Fertility (Cambridge, England)|December 2, 2010
Androgens, health and sexuality in women and menKevan Wylie, Margaret Rees, Geoff Hackett, et al.
Pageof 5